SECsense Logo

Dexcom, Inc. 8-K Filing Report: Key Insights & Future Expectations

$DXCM
Form 8-K
Filed on: 2025-03-25
Source
Dexcom, Inc. 8-K Filing Report: Key Insights & Future Expectations

Based on the provided XML section of the financial report, here are the key pieces of information extracted:

  1. Company Information:
  • Name: Dexcom, Inc.
  • State of Incorporation: Delaware (DE)
  • CIK (Central Index Key): 0001093557
  • SEC File Number: 000-51222
  • IRS Employer Identification Number (EIN): 33-0857544
  • Address: 6340 Sequence Drive, San Diego, CA 92121
  • Phone Number: 858-200-0200
  1. Stock Information:
  • Type of Stock: Common Stock
  • Par Value per Share: $0.001
  • Ticker Symbol: DXCM
  • Exchange: NASDAQ
  1. Filing Information:
  • Filing Type: 8-K (Current Report)
  • Filing Date: March 21, 2025
  1. Reporting Period:
  • Start Date of Report: March 21, 2025
  • End Date of Report: March 21, 2025

Insights:

  • The report is a current 8-K filing, which typically indicates that the company is disclosing significant events or changes that are important for shareholders and investors.
  • The filing date matches the reporting period, suggesting that it may contain immediate or recent information regarding company operations or events.
  • Dexcom, Inc. is a publicly traded company listed on NASDAQ, indicating that it has to adhere to strict regulatory requirements for disclosures.
  • As the filing is dated in the future (2025), it suggests that this information may pertain to future expectations or a planned event that has been disclosed early.

This summary provides an overview of the essential details from the financial report section, which can be useful for stakeholders assessing Dexcom, Inc.'s financial situation and compliance with SEC regulations.